Anticholinergic therapy: do the patients take the pills prescribed?
- 3 November 2010
- journal article
- general gynecology
- Published by Springer Science and Business Media LLC in Archiv für Gynäkologie
- Vol. 284 (3), 663-666
- https://doi.org/10.1007/s00404-010-1720-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract SymptomsObstetrics & Gynecology, 2008
- Survey Assessment of Continuation of and Satisfaction with Pharmacological Treatment for Urinary IncontinenceValue in Health, 2008
- Anticholinergic drugs versus other medications for overactive bladder syndrome in adultsCochrane Database of Systematic Reviews, 2007
- The Current and Future Burden and Cost of Overactive Bladder in Five European CountriesEuropean Urology, 2006
- Persistence and Adherence of Medications for Chronic Overactive Bladder/Urinary Incontinence in the California Medicaid ProgramValue in Health, 2005
- Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladderWorld Journal of Urology, 2005
- Prevalence and burden of overactive bladder in the United StatesWorld Journal of Urology, 2003
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladderBritish Journal of Urology, 1998
- A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder complianceBJOG: An International Journal of Obstetrics and Gynaecology, 1997